The "Bioprocess Filtration: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for bioprocess filtration is estimated to grow from $8.4 billion in 2025 to ...
3don MSN
2025’s best-performing Minnesota public company stock is a biopharmaceutical firm with no revenue
The runaway winner among Minnesota-based public company stocks in 2025 was a company with no revenue but huge promise. Plymouth-based Celcuity, a clinical stage biopharmaceutical company, is ...
Transcenta Therapeutics, a global biopharmaceutical company with capabilities in discovery, research, development and ...
About Transcenta Therapeutics Transcenta (HKEX: 06628) is a global clinical stage biopharmaceutical company with fully integrated capabilities in antibody-based biotherapeutics discovery, research, ...
FUJIFILM Corporation today announced the completion of one of Japan’s largest bio CDMO*1 facilities (the new plant) at the ...
Under the ongoing collaboration Remedy Cell’s personnel, along with Pluri’s Contract Development and Manufacturing Organization (“CDMO”) division (PluriCDMO™), have successfully completed the full ...
ABEC Inc., manufacturer of stainless-steel containers for biopharmaceutical production, is in growth mode, with its ...
Dublin, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Process Analytical Technology Market - Global Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback